| 标题 |
First-in-human, phase 1 study of CM512, a TSLP/IL-13 bispecific antibody, in healthy volunteers: safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity |
| 网址 | |
| DOI | |
| 其它 |
期刊:Frontiers in Immunology 作者:Yue Cheng; Qingfeng Liu; Mengmeng Li; Yao Xie; Yuchun Men; et al 出版日期:2026 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)